Findings From These Studies Could Save Thousands of Lives Through Better Understanding the Mechanistic Basis of Chronic Wound Infection
ORLANDO, FL / ACCESSWIRE / May 6, 2024 / MicroGenDX, a global leader in next-generation sequencing (NGS) diagnostics of infection, and members from the academic lab of Caleb Phillips at Texas Tech University (TTU) will present four groundbreaking oral presentations at the Wound Healing Society meeting in May 2024. Based on the microbial profiles provided to physicians through MicroGenDX clinical reports, the presentation of these studies was made possible with joint support from the National Institutes of Health and the Southwest Regional Wound Care Center (SWRWCC; Joe Wolcott, M.D.).
“We couldn’t be more proud of our research collaborators and their accomplishments in presenting the findings of these game-changing MicroGenDX-supported studies,” said Rick Martin, MicroGenDX CEO. “These collaborations are just another example of MicroGenDX’s dedication to promoting better infectious disease treatment through our technology, scientific research, and the development of researchers and physicians.”
Each presentation will summarize the different initiatives that have been made to understand the mechanistic basis of chronic wound infection and treatment, and all studies have been based on the microbial profiles provided to physicians through MicroGenDX clinical reports.
Study #1: Local weather conditions influence wound infection profiles and the likelihood of antimicrobial resistance gene detection
Presented by Craig Tipton, Ph.D., and Director of Biostatistics at MicroGenDX
Study #2: Bacterial relative abundance profiles from the MicroGenDX clinical reports were the single biggest explainer of healing time
Presented by Jake Ancira, M.S., and research analyst at MicroGenDX
Study #3: Elucidating genetic predisposition to infection using genome-wide associations
Presented by Rebecca Gabrilska, M.D./Ph.D. student at TTU Health Sciences Center, and Phillips Lab
Study #4: How patients’ tissue-specific gene expression predicts differences in species infecting chronic wounds
Presented by Khalid Omeir, current graduate student at TTU in the Phillips Lab and bioinformatics intern at MicroGenDX
For more information about these studies, visit: https://advancedwoundcareusa.com/
Contact Information
James Campagno
Director of Marketing
james.compgano@microgendx.com
(407) 863-0043
SOURCE: MicroGenDX
View the original press release on newswire.com.
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…